 T2 Biosystems Inc NASDAQ: TTOO expects Q2 FY22 revenues of 5.8 million - 6.1 million, below the consensus of 6.87 million. The interim numbers include product revenue of 2.5 million - 2.7 million and research revenue of 3.3 million - 3.4 million. 